Douglas Ingram
2020
Compensation breakdown
| Non-Equity Incentive Plan | $605,475 |
|---|---|
| Salary | $669,250 |
| Other | $17,222 |
| Total | $1,291,947 |
Ingram received $669.3K in salary, accounting for 52% of the total pay in 2020.
Ingram also received $605.5K in non-equity incentive plan and $17.2K in other compensation.
Rankings
In 2020, Douglas Ingram's compensation ranked 7,513th out of 13,090 executives tracked by ExecPay. In other words, Ingram earned more than 42.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,513 out of 13,090 | 43rd |
Division Manufacturing | 3,162 out of 5,621 | 44th |
Major group Chemicals And Allied Products | 1,273 out of 2,254 | 44th |
Industry group Drugs | 1,100 out of 1,954 | 44th |
Industry Pharmaceutical Preparations | 821 out of 1,459 | 44th |
Pay ratio
| Douglas Ingram's Pay | $1,291,947 |
|---|---|
| Median Employee's Pay | $275,247 |
| Pay Ratio | 5to 1 |
In 2020, the annual total compensation of Douglas Ingram was $1,291,947.
The annual total compensation of the median employee at Sarepta Therapeutics was $275,247.
The ratio of Douglas Ingram's pay to the pay of median employee was therefore 5 to one.
Ingram's colleagues
We found seven more compensation records of executives who worked with Douglas Ingram at Sarepta Therapeutics in 2020.
2020
Louise Rodino-Klapac
Sarepta Therapeutics
Chief Scientific Officer
2020
David Howton
Sarepta Therapeutics
General Counsel
2020
Ian Estepan
Sarepta Therapeutics
Chief Financial Officer
2020
Gilmore MMSc
Sarepta Therapeutics
Chief Scientific Officer
2020
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2020
Joseph Bratica
Sarepta Therapeutics
Vice President, Corporate Controller
2020
William Ciambrone
Sarepta Therapeutics
Executive Vice President, Technical Operations
News
April 25, 2022
April 20, 2021
April 21, 2020
April 26, 2019